Completed
CTNPT 027: the Lilac Study
The effect of metformin on HIV reservoir size in non-diabetic ART-treated patients
Learn MoreCompleted
The effect of metformin on HIV reservoir size in non-diabetic ART-treated patients
Learn MoreCompleted
Brain imaging to understand HIV-associated neurocognitive disorder and predict response to cognitive training
Learn MoreReporting
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
Learn MoreReporting
Use of non-invasive methods for diagnosis of non-alcoholic steatohepatitis (NASH) in HIV patients and therapeutic use of vitamin E
Learn MoreCompleted
Rifabutin Therapy for the Prevention of MAC in Patients with AIDS
Learn MoreReporting
A pilot study of a novel, mRNA-based assay for the diagnosis of anal HPV infection HIV-positive MSM
Learn MoreOngoing
Terminated
Probiotic Visbiome for Inflammation and Translocation in HIV (PROOV IT I)
Learn MoreReporting
Bone Antiresorptive Therapy with AntiRetroviral Initiation (BATARI) Pilot Trial
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.